cells

IgG lambda myeloma plasma cell line known as EJM was established from a peritoneal effusion from a patient with extramedullary myeloma Br J Haematol. 1990 Jul;75(3):378-84. Characterization of new IgG lambda myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myeloma. Hamilton MS, Ball J, Bromidge E, Lowe J, Franklin IM. SourceDepartment of Immunology and Haematology, Queen Elizabeth Medical Centre, Edgbaston, Birmingham.

Cell Type:

Myeloid (unspec.)

Tissue Origin:

Species:

human

Research Area:

Cancer Research/Cell Biology

Cell Characteristics:

Suspension

Transfection Information

Lonza Optimized Protocol
Optimization Guideline

Filter:

The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.

Protocol	Kit	Program	Cells	Efficiency	Viable Cells	Substrate		Format	Platform
	R	T-030	4e6	51%	77%	Plasmid (general)	4 µg	100 µl	I/II/2b
	R	X-010	4e6	50%	74%	Plasmid (general)	4 µg	100 µl	I/II/2b